Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Cefuroxime sodium
Drug ID BADD_D00409
Description Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, gonorrhea, and haemophilus.
Indications and Usage For the treatment of many different types of bacterial infections such as bronchitis, sinusitis, tonsillitis, ear infections, skin infections, gonorrhea, and urinary tract infections.
Marketing Status Prescription
ATC Code J01DC02; S01AA27
DrugBank ID DB01112
KEGG ID D00915
MeSH ID D002444
PubChem ID 23670318
TTD Drug ID D0Y2IE
NDC Product Code 25021-118; 25021-182; 25021-183; 52946-0905; 25021-119
Synonyms Cefuroxime | Cephuroxime | Zinacef | Ketocef
Chemical Information
Molecular Formula C16H15N4NaO8S
CAS Registry Number 56238-63-2
SMILES CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-].[Na+]
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Rash23.03.13.001--Not Available
Seizure17.12.03.001--
Stevens-Johnson syndrome10.01.03.020; 23.03.01.007; 12.03.01.014; 11.07.01.005--
Thrombocytopenia01.08.01.002--Not Available
Thrombophlebitis24.01.02.001--Not Available
Toxic epidermal necrolysis12.03.01.015; 11.07.01.006; 10.01.01.006; 23.03.01.008--
Urticaria23.04.02.001; 10.01.06.001--
Vomiting07.01.07.003--
Vulvovaginal candidiasis21.14.02.003; 11.03.03.005--Not Available
Tubulointerstitial nephritis20.05.02.002--Not Available
Haemorrhage24.07.01.002--Not Available
Blood alkaline phosphatase increased13.04.02.004--
Coombs test positive13.01.01.002--Not Available
Toxicity to various agents12.03.01.046--Not Available
The 2th Page    First    Pre   2    Total 2 Pages